Astellas moves into vaccine technology through Japanese deal
24 July 2009
Ian Haydock
Please Login to read the full article.
24 July 2009
Ian Haydock
ian.haydock@informa.com
Astellas has signed an agreement with the Japanese bioventure REGiMMUNE to develop platform technology for the development and delivery of vaccines.
The partners said that the collaboration would build on Astellas's expertise in screening compounds derived from natural sources and REGiMMUNE's...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Isotechnika buoyed by deal with Vifor for voclosporin in lupus
- Astellas locks in global rights to Vical's CMV vaccine for transplant use
- Positive Phase III data for LifeCycle's 'improved Prograf' despite higher drop-out
- Astellas gains full control of Maxygen joint venture Perseid
COMMENT
Other Informa Comment
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
